In one study, 5 out of 41 COVID-19 patients showed SARS-COV-2-related myocardial injury, mainly manifested by increased levels of high-sensitivity cardiac troponin I (hs-cTnI) levels (>28 pg/mL) in Wuhan [88]. This evidence concerns the gene TNNI3 and COVID-19.